Place the Title here
Advanced gastroesophageal adenocarcinoma (GEA) and biliary tract cancers (BTC) require treatment plans that are specifically TAILORed for each patient. Understanding the impact of HER2 and the latest advancements in assessment and management are key elements to effectively target tumors and optimize outcomes in advanced GEA and BTC.
Clinical Perspective
Patient & Caregiver
This activity is provided by Med Learning Group.
This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
Copyright © 2024 TAILOR. All Rights Reserved. Website by Divigner.